{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:03:08Z","timestamp":1769266988127,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Institute of Information & communications Technology Planning & Evaluation *IITP) grant funded by the Korea govenment"},{"name":"A grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea"},{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government"},{"name":"The Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean Government"},{"name":"Future Medicine 20*30 Project of the Samsung Medical Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cmpb.2025.108915","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:51:07Z","timestamp":1749898267000},"page":"108915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unraveling the tumor-microenvironment through a radiogenomic-based multiomic approach to predict outcomes of immunotherapy in non-small cell lung cancer"],"prefix":"10.1016","volume":"269","author":[{"given":"Dong Young","family":"Jeong","sequence":"first","affiliation":[]},{"given":"Cheol Yong","family":"Joe","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7627-2000","authenticated-orcid":false,"given":"Sang Min","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Sehhoon","family":"Park","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-1920","authenticated-orcid":false,"given":"Seung Hwan","family":"Moon","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1060-0096","authenticated-orcid":false,"given":"Joon Young","family":"Choi","sequence":"additional","affiliation":[]},{"given":"Jonghoon","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Se-Hoon","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Ho Yun","family":"Lee","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.cmpb.2025.108915_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non\u2013small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ettinger","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.cmpb.2025.108915_bib0002","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0003","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non\u2013small-cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0004","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038089","article-title":"Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors","volume":"13","author":"Park","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0006","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.annonc.2021.07.007","article-title":"The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition","volume":"32","author":"Loi","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0007","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.21.02010","article-title":"Artificial intelligence\u2013Powered spatial analysis of tumor-infiltrating lymphocytes as complementary biomarker for immune checkpoint inhibition in non\u2013Small-cell lung cancer","volume":"40","author":"Park","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0008","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1019062","article-title":"The types of tumor infiltrating lymphocytes are valuable for the diagnosis and prognosis of breast cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.cmpb.2025.108915_bib0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fimmu.2020.00364","article-title":"Characteristics of tumor-infiltrating lymphocytes prior to and during immune checkpoint inhibitor therapy","volume":"11","author":"Plesca","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of tumor infiltrating leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.cmpb.2025.108915_bib0012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jtho.2017.09.1958","article-title":"Molecular adequacy of image-guided rebiopsies for Molecular retesting in advanced non\u2013Small cell lung cancer: a single-center experience","volume":"13","author":"Tokaca","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0013","doi-asserted-by":"crossref","first-page":"A143","DOI":"10.1016\/j.jval.2016.03.1556","article-title":"Costs and outcomes comparison of tissue and blood based biopsies for the purpose of biomarker testing","volume":"19","author":"Arnaud","year":"2016","journal-title":"Value in Health"},{"key":"10.1016\/j.cmpb.2025.108915_bib0014","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2017170347","article-title":"Feasibility and safety of intrathoracic biopsy and repeat biopsy for evaluation of programmed cell death ligand\u20131 expression for immunotherapy in non\u2013Small cell lung cancer","volume":"287","author":"Tsai","year":"2018","journal-title":"Radiology."},{"key":"10.1016\/j.cmpb.2025.108915_bib0015","article-title":"Economic analysis of tissue-first, plasma-first, and complementary NGS approaches for treatment-naive metastatic lung adenocarcinoma","volume":"12","author":"Yang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0016","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231227","article-title":"Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: correlation with immune profiles","volume":"15","author":"Yoon","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.cmpb.2025.108915_bib0018","first-page":"1","article-title":"Development of an immune-pathology informed radiomics model for non-small cell lung cancer","volume":"8","author":"Tang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2025.108915_bib0019","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13244-023-01575-7","article-title":"The effect of feature normalization methods in radiomics","volume":"15","author":"Demircioglu","year":"2024","journal-title":"Insights. ImAging"},{"key":"10.1016\/j.cmpb.2025.108915_bib0020","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1198\/016214506000000735","article-title":"The adaptive lasso and its oracle properties","volume":"101","author":"Zou","year":"2006","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.cmpb.2025.108915_bib0021","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J. R. Stat. Soc. B: Stat. Methodol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0022","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00401706.1970.10488634","article-title":"Ridge regression: biased estimation for nonorthogonal problems","volume":"12","author":"Hoerl","year":"1970","journal-title":"Technometrics."},{"key":"10.1016\/j.cmpb.2025.108915_bib0023","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"Journal of the Royal Statistical Society Series B: Statistical Methodology"},{"key":"10.1016\/j.cmpb.2025.108915_bib0024","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45: a critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.928328","article-title":"A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery","volume":"13","author":"Ye","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.cmpb.2025.108915_bib0026","article-title":"Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0027","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.2147\/CMAR.S257692","article-title":"Tumor-associated CD163+ M2 macrophage infiltration is highly associated with PD-L1 expression in cervical cancer","author":"Guo","year":"2020","journal-title":"Cancer Manage Res."},{"key":"10.1016\/j.cmpb.2025.108915_bib0028","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.2147\/CMAR.S274913","article-title":"PD-L1 expression is highly associated with tumor-associated macrophage infiltration in nasopharyngeal carcinoma","author":"Deng","year":"2020","journal-title":"Cancer Manage Res."},{"key":"10.1016\/j.cmpb.2025.108915_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2022.8284","article-title":"Differential expression of PD\u2011L1 and PD\u2011L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non\u2011small cell lung cancer","volume":"47","author":"Sumitomo","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cmpb.2025.108915_bib0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI96113","article-title":"Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade\u2013mediated tumor regression","volume":"128","author":"Lin","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cmpb.2025.108915_bib0031","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cam4.1518","article-title":"Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases","volume":"7","author":"Dhupkar","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.cmpb.2025.108915_bib0032","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1158\/0008-5472.CAN-18-3208","article-title":"Anti\u2013PD-L1 treatment results in functional remodeling of the macrophage compartment","volume":"79","author":"Xiong","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.cmpb.2025.108915_bib0033","article-title":"Influence of tumor immune infiltration on immune checkpoint inhibitor therapeutic efficacy: a computational retrospective study","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0034","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1200\/PO.20.00150","article-title":"Meta-analysis of PD-L1 expression as a predictor of survival after checkpoint blockade","volume":"4","author":"Arfe","year":"2020","journal-title":"JCo Precis. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.annonc.2020.01.065","article-title":"Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas","volume":"31","author":"Schoenfeld","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0036","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/RCT.0000000000001149","article-title":"Preliminary computed tomography radiomics model for predicting pretreatment CD8+ T-cell infiltration status for primary head and neck squamous cell carcinoma","volume":"45","author":"Wang","year":"2021","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.cmpb.2025.108915_bib0037","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1007\/s00330-019-06581-2","article-title":"Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma","volume":"30","author":"Cho","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.cmpb.2025.108915_bib0038","article-title":"Imaging-based biomarkers predict programmed death-ligand 1 and survival outcomes in advanced NSCLC treated with Nivolumab and Pembrolizumab: a multi-institutional study","volume":"4","author":"Yolchuyeva","year":"2023","journal-title":"JTo Clin. Res. Rep."},{"key":"10.1016\/j.cmpb.2025.108915_bib0039","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12967-024-04854-z","article-title":"Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics","volume":"22","author":"Yolchuyeva","year":"2024","journal-title":"J. Transl. Med."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260725003323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260725003323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T06:04:38Z","timestamp":1754460278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260725003323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"alternative-id":["S0169260725003323"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2025.108915","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the tumor-microenvironment through a radiogenomic-based multiomic approach to predict outcomes of immunotherapy in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2025.108915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108915"}}